|
⚲
|
| Keyboard |
| Norby R Douglas
✚
|
|
|---|---|
| CIK # | 0001227001 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001227001] | |
| 4 | [0001227001] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Krystal Biotech Inc | |
| Norby R Douglas | |
| Alexion Pharmaceuticals Inc | |
| Magnachip Semiconductor Corp | |
| InvenSense Inc | |
| Ikanos Communications Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Krystal Biotech Inc KRYS
Stock Option (Right to Buy) · derivative
|
2018-05-31 | Grant | 7,500 | $0.00 | |
|
Krystal Biotech Inc KRYS
Common Stock
|
2018-05-09 | Buy | 9,000 | $10.42 | 93,780 |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2017-05-10 | Grant | 2,030 | $0.00 | |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2016-09-23 | Option exercise | 1,774 | $131.97 | 234,115 |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2016-09-23 | Option exercise | 7,202 | $128.81 | 927,690 |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2016-09-23 | Option exercise | 2,800 | $130.03 | 364,084 |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2016-09-23 | Option exercise | 3,724 | $131.10 | 488,216 |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2016-05-11 | Grant | 835 | $0.00 | |
|
Alexion Pharmaceuticals Inc ALXN
Option to Purchase Common Stock · derivative
|
2016-05-11 | Grant | 2,294 | $138.86 | 318,545 |
|
Magnachip Semiconductor Corp MX
Stock Option (Right to Buy) · derivative
|
2016-03-11 | Grant | 29,478 | $0.00 | |
|
Magnachip Semiconductor Corp MX
Common Stock
|
2016-03-11 | Grant | 6,314 | $0.00 | |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2015-12-11 | Sell | 35,575 | $187.57 | 6,672,803 |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2015-12-11 | Sell | 9,833 | $188.24 | 1,850,964 |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2015-12-11 | Grant | 3,425 | $96.35 | 329,999 |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2015-12-11 | Sell | 34 | $186.97 | 6,357 |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2015-12-11 | Grant | 3,237 | $85.75 | 277,573 |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2015-12-11 | Grant | 13,000 | $18.01 | 234,130 |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2015-12-11 | Grant | 12,276 | $16.83 | 206,605 |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2015-12-11 | Grant | 7,932 | $26.64 | 211,308 |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2015-12-11 | Grant | 5,572 | $49.43 | 275,424 |
| showing 20 of 59 most recent transactions | |||||